oncoXchange.org is the new precision-medicine platform dedicated to transforming medical education and accelerating knowledge translation into clinical practice to improve patient outcomes.
Lead by a world-renowned scientific board, oncoxchange.org Breast Cancer Edition is medcomXchange’s first peer-to-peer, secure digital-health platform and will be followed by editions dedicated to other areas in oncology.
oncoXchange provides leading educational opportunities and facilitates collaboration between researchers and clinicians. We support the scientific community by offering a stage for the next generation of thought leaders to develop.
As internationally-recognized leaders in the field of cancer research, the members of the oncoXchange.org Editorial Board guide the platform with unparalleled expertise and insight.
Kathleen Pritchard, MD
Dr. Pritchard is a medical oncologist and clinical trials research scientist. Her areas of interest include multicentre clinical trials; adjuvant, biologic and hormonal therapy for breast cancer; correlative and translational research in breast cancer; banking of tumour, tissue, serum and data; and predictive and prognostic factors in breast cancer. According to Thomson Reuters, Pritchard was one of the most cited researchers in the world in 2014 and 2015.
Edith Perez, MD
Edith A. Perez, M.D., is the Serene M. and Frances C. Durling Professor of Medicine at Mayo Clinic College of Medicine. Dr. Perez is a cancer specialist and an internationally known translational researcher. Her roles extend nationally, including group vice chair of the Alliance for Clinical Trials in Oncology and other positions within the American Association for Cancer Research, the American Society of Clinical Oncology and the National Cancer Institute.
John Bartlett BSc, PhD
Pr. John Bartlett’s research is focused on the development of novel diagnostic approaches to stratified medicine predominantly in breast and prostate cancer. He is developing and validating novel approaches to molecular diagnostics in cancer. He is the author of over 125 papers. Dr John Bartlett is also involved in the TRANSBIG research network and in scientific working groups as part of the Breast International Group (BIG) network.
Have a question?
Want to create a group?
Reach us at oncoXchange, the precision-medicine platform.